Avantika Medex Private Limited

Avantika Medex Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U51397GJ2007PTC082606 Incorporated 18 September 2007 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2025
₹44.37 Cr
▼ 14% YoY
Net profit · FY 2025
₹1.75 Cr
Net margin 3.9%
EBITDA · FY 2025
₹4.54 Cr
EBITDA margin 10.2%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.03 Cr
Issued & subscribed
Open charges
₹1.13 Cr
Satisfied ₹20.97 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
138
Provident fund records

About Avantika Medex Private Limited

Data last updated:

Avantika Medex Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Avl Life Science Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 September 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51397GJ2007PTC082606. Its GSTIN is 24AAGCA5648H1ZO (Gujarat).

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.03 Cr. It is led by directors Vibha Rani Singh and Lal Babu Singh.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1308 Shapath – V Near Prahalad Nagar Junction S.G.Road Vejalpur, Ahmedabad, Gujarat, India – 380051.

As per the financials filed for FY 2025, the company reported a revenue of ₹44.37 Cr, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹1.75 Cr (net margin 3.9%) and EBITDA of ₹4.54 Cr (EBITDA margin 10.2%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 18% over five years.

The company has about 138 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹1.13 Cr and satisfied charges of ₹20.97 Cr on record. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it. The company has 1 deal on record (1 rights issue); the latest was in April 2019. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Admed Pharma Private Limited with revenue of ₹44.5 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 4 overdue payments to 2 micro and small suppliers.

Avantika Medex Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0034308). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website avantikamedexpl.com.

Company details

CIN U51397GJ2007PTC082606
Registration Number 082606
Incorporation Date 18 September 2007
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Parent Company Avl Life Science Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-01-0034308

CIN history

Avantika Medex has one previous CIN (Corporate Identification Number): U51397DL2007PTC168345. The current CIN is U51397GJ2007PTC082606, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51397GJ2007PTC082606Current
U51397DL2007PTC168345Previous

Recognitions & Rankings of Avantika Medex

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-GJ-01-0034308

Contact details

Avantika Medex Private Limited's registered office is in Ahmedabad, Gujarat. Its website is avantikamedexpl.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    1308 Shapath – V Near Prahalad Nagar Junction S.G.Road Vejalpur, Ahmedabad, Gujarat, India – 380051
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Avantika Medex Private Limited, buy the company report.

Comprehensive company report
Avantika Medex Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Avantika Medex is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Avantika Medex Private Limited, buy the company report.

Financials of Avantika Medex Private Limited

FY 2024 filings available

Avantika Medex Private Limited reported revenue of ₹44.37 Cr (down 14% YoY) for FY 2025.

Revenue · FY 2025
₹44.37 Cr ▼ 14%
Net profit · FY 2025
₹1.75 Cr margin 3.9%
EBITDA · FY 2025
₹4.54 Cr margin 10.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 14%
3 years · compounded
▼ 1%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▼ 44%
3 years · compounded
▼ 13%
5 years · compounded
▲ 11%

Revenue fell 14% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 18%. EBITDA fell 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.54 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.75 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin10.2%
Net Profit Margin3.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Avantika Medex Private Limited, buy the company report.

Board of directors of Avantika Medex Private Limited

Avantika Medex has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Vibha Rani SinghDirector18 Sep 200719 Years 1 MonthsCurrent
Lal Babu SinghDirector18 Sep 200719 Years 1 MonthsCurrent

Peer comparison

Avantika Medex Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Admed Pharma Private Limited₹44.5 Cr (FY 2025)17.0%Delhi, India
Lincoln Parenteral Limited₹44.48 Cr (FY 2020)-13.0%Ahmedabad, Gujarat, India
Avantika Medex Private Limitedthis company₹44.37 Cr (FY 2025)₹1.75 Cr3.9%-14.0%138Ahmedabad, Gujarat, India
Lexicon Worldwide Limited₹44.19 Cr (FY 2024)37.0%Solan Hp, Himachal Pradesh, India
Affine Formulations Limited₹44.05 Cr (FY 2022)4.0%Indore, Madhya Pradesh, India
Quality Pharma Products Private Limited₹43.95 Cr (FY 2025)22.0%Assam, India

To see the full peer comparison of Avantika Medex Private Limited, buy the company report.

Auditor

Avantika Medex Private Limited is audited by LAKHANI ISMAILI TUNDIYA & CO for the financial year 2024.

Auditor firmFinancial yearFirm registration number
LAKHANI ISMAILI TUNDIYA & COFY 2024119573W

Shareholding

The shareholding of Avantika Medex Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Avantika Medex Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.13 Cr
Satisfied charges
₹20.97 Cr
Breakdown by lending institutions
Axis Bank Limited₹0.93 Cr
Hdfc Bank Limited₹0.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
15 Dec 2022100654925Axis Bank Limited₹93.07 LakhOpen
05 Feb 201410476307Hdfc Bank Limited₹20 LakhOpen
29 Dec 2023100862070Others₹9.9 CrSatisfied
04 Oct 2019100303673The South Indian Bank Limited₹9.62 CrSatisfied
05 May 201510581573Hdfc Bank Limited₹1.46 CrSatisfied

To see the full charge records of Avantika Medex Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Avantika Medex Private Limited has 1 deal on record (1 rights issue); the latest was in April 2019.

Total deals
1
Rights issue
1

Deals on record (1 of 1)

WhenDealAmountParties
Apr 2019Rights issue₹2.37 CrInvestors: Avl Life Science Private Limited , 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Avantika Medex Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 4 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (2 of 2)

SupplierAmount dueDue sinceReported on
an individual supplier
Nexus Infratech Private Limited

To see the full MSME payment records of Avantika Medex Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Avantika Medex Private Limited has a workforce of 138 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
138
Active EPFO establishments
1
Employee growth
12.2%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27138
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20

To see the full employee and EPFO history of Avantika Medex Private Limited, buy the company report.

GST

Avantika Medex has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAGCA5648H1ZOGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Avantika Medex Private Limited, buy the company report.

Recent activity

Avantika Medex Private Limited has 2 board changes on record since 2007: 2 appointments. The latest: Lal Babu Singh was appointed as Director on 18 Sep 2007.

Charges
A charge registered on 29 Dec 2023 via Charge ID 100862070 with Others was fully satisfied on 27 Nov 2025.
AGM
Avantika Medex Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others of Rs. 9.90 Cr registered on 29 Dec 2023 with Charge ID 100862070 was modified on 05 Apr 2024.
Filing
Avantika Medex Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
A charge registered on 05 May 2015 via Charge ID 10581573 with Hdfc Bank Limited was fully satisfied on 11 Mar 2024.
Charges
A charge registered on 04 Oct 2019 via Charge ID 100303673 with The South Indian Bank Limited was fully satisfied on 09 Feb 2024.
Charges
A charge with Others amounted to Rs. 9.90 Cr with Charge ID 100862070 was registered on 29 Dec 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.93 Cr with Charge ID 100654925 was registered on 15 Dec 2022.
Charges
A charge with Hdfc Bank Limited of Rs. 1.46 Cr registered on 05 May 2015 with Charge ID 10581573 was modified on 26 Jul 2022.
Charges
A charge with The South Indian Bank Limited of Rs. 9.62 Cr registered on 04 Oct 2019 with Charge ID 100303673 was modified on 24 Jun 2022.
Charges
A charge with The South Indian Bank Limited amounted to Rs. 9.62 Cr with Charge ID 100303673 was registered on 04 Oct 2019.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.46 Cr with Charge ID 10581573 was registered on 05 May 2015.

4 earlier events are in the company report.

Frequently asked questions

Avantika Medex is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 September 2007 (19+ years old) and is registered under CIN U51397GJ2007PTC082606.

Avantika Medex has 2 current directors:

The latest financial statements of Avantika Medex on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Avantika Medex is 24AAGCA5648H1ZO, registered in Gujarat.

The CIN (Corporate Identification Number) of Avantika Medex is U51397GJ2007PTC082606. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Avantika Medex has 4 court cases on record: 1 filed by the company and 3 filed against it. Most are in the district courts.

Avantika Medex was incorporated on 18 September 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Avantika Medex has 1 deal on record (1 rights issue); the latest was in April 2019.

The peers of Avantika Medex by revenue are Admed Pharma Private Limited, Lincoln Parenteral Limited, Lexicon Worldwide Limited, Affine Formulations Limited, Quality Pharma Products Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Lal Babu Singh was appointed as Director on 18 Sep 2007. Vibha Rani Singh was appointed as Director on 18 Sep 2007.

Yes, Avantika Medex is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-01-0034308).

Avantika Medex has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 4 overdue payments to 2 micro and small suppliers. The latest return was filed on 08 Jun 2019.